Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.
Zacks Investment Research on MSN
MRK stock trading above 200- & 50-day SMA for 2 months: Time to buy?
Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, ...
A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback